Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Generale denteXPAR:GDS 71 EBITDA Margin % is 12.48% as of Jun. 2026, which is 6% above its 10-year median of 11.73. GuruFocus rates XPAR:GDS with a GF Score™ of 71/100 and a GF Value™ of €12.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Ramsay Generale dente ranks better than 56.78% on this metric.
Ramsay Generale dente (XPAR:GDS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ramsay Generale dente EBITDA Margin % Related Terms
Ramsay Generale dente EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ramsay Generale dente's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:GDS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ramsay Generale dente's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Generale dente EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ramsay Generale dente's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Generale dente (XPAR:GDS) has a EBITDA Margin % of 12.48% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ramsay Generale dente and its competitors. This is near median its historical median of 11.73. Over the past decade, Ramsay Generale dente's EBITDA Margin % has ranged from 8.38 to 15.74. According to the industry distribution chart, Ramsay Generale dente ranks #290 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 43.2%.
Is Ramsay Generale dente's EBITDA Margin % too high?
Ramsay Generale dente's current EBITDA Margin % of 12.48% is near median its 10-year median of 11.73. Over the past 10 years, this metric has ranged from a low of 8.38 to a high of 15.74. The Healthcare Providers & Services industry median EBITDA Margin % is 10.09. Ramsay Generale dente's value of 12.48% is 23.7% above this industry median. Based on the distribution chart, Ramsay Generale dente ranks #290 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ramsay Generale dente has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Generale dente ranks #290 out of 671 companies for EBITDA Margin %. This puts Ramsay Generale dente in the upper half of its industry. The industry median EBITDA Margin % is 10.09. Ramsay Generale dente's value of 12.48% is 23.7% above this benchmark. Historically, Ramsay Generale dente's own EBITDA Margin % has ranged from 8.38 to 15.74 over the past decade. While the company's 10-year median is 11.73 vs. the industry median of 10.09, Ramsay Generale dente has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.09, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Generale dente's current EBITDA Margin % of 12.48% is 23.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ramsay Generale dente and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current EBITDA Margin % is 12.48%, which is near median its own 10-year median of 11.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Generale dente (XPAR:GDS) is currently considered Fairly Valued. The stock's GF Value™ is €12.04, compared to a current price of €11.00 — trading 8.6% below its estimated fair value. The current EBITDA Margin % is 12.48%, which is near median its 10-year median of 11.73 and 23.7% above the Healthcare Providers & Services industry median of 10.09. Ramsay Generale dente's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ramsay Generale dente (XPAR:GDS), the current EBITDA Margin % is 12.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Generale dente (XPAR:GDS) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued.
The current stock price of €11.00 is trading 8.6% below its estimated GF Value™ of €12.04.
GuruFocus considers Ramsay Generale dente to be Fairly Valued.
Key valuation signals for XPAR:GDS:
EBITDA Margin %: 12.48% (near median its 10-year median of 11.73)
GF Value™: €12.04 vs. price of €11.00 (8.6% below fair value)
Industry Position: 23.7% above the Healthcare Providers & Services median (#290 of 671)
No single metric tells the full story. See the XPAR:GDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score
Get the complete analysis for XPAR:GDS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:GDS has been successfully added to your 
